U.S. federal trademark · Serial No. 90874377
pharmaceutical preparations, namely, cell therapy products utilizing t-cell therapy for use in treating disease; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations in the nature of genetically modified cells, namely, genetically modified immune cells for use in human therapeutics and in the treatment of cancer
Medical services, namely, cellular immunotherapy treatments utilizing chimeric antigen receptor t cells for use in treating disease, namely, the treatment of cancer
pharmaceutical research and development services; scientific research in the field of cellular immunotherapy utilizing chimeric antigen receptor t cells for use in treating cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.